Active, not recruitingPhase 2

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

NCT06079190

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

San Diego, California, United States

+96 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2023-10-20
Enrollment: 367 participants
Sponsor: GlaxoSmithKline
Purpose: treatment

Locations (97)

GSK Investigational SiteSan Diego, California, United States
GSK Investigational SiteLake Mary, Florida, United States
GSK Investigational SiteLake Worth, Florida, United States
GSK Investigational SiteMaitland, Florida, United States
GSK Investigational SiteMiami, Florida, United States
GSK Investigational SiteOrlando, Florida, United States
GSK Investigational SiteOrlando, Florida, United States
GSK Investigational SiteStuart, Florida, United States
GSK Investigational SiteThe Villages, Florida, United States
GSK Investigational SiteThe Villages, Florida, United States
GSK Investigational SiteDecatur, Georgia, United States
GSK Investigational SiteElk Grove Village, Illinois, United States
GSK Investigational SiteChesterfield, Missouri, United States
GSK Investigational SiteToms River, New Jersey, United States
GSK Investigational SiteStaten Island, New York, United States
GSK Investigational SiteMatthews, North Carolina, United States
GSK Investigational SiteNorth Canton, Ohio, United States
GSK Investigational SiteOklahoma City, Oklahoma, United States
GSK Investigational SitePortland, Oregon, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteFairfax, Virginia, United States
GSK Investigational SiteBuenos Aires, Argentina
GSK Investigational SiteBuenos Aires, Argentina
GSK Investigational SiteCiudad Autonoma de Buenos Aire, Argentina
GSK Investigational SiteCiudad Autonoma de Bueno, Argentina
GSK Investigational SiteCamperdown, New South Wales, Australia
GSK Investigational SiteDarlinghurst, New South Wales, Australia
GSK Investigational SiteKogarah, New South Wales, Australia
GSK Investigational SiteMacquarie Park, New South Wales, Australia
GSK Investigational SiteGold Coast, Queensland, Australia
GSK Investigational SiteHeidelberg, Victoria, Australia
GSK Investigational SiteNedlands, Western Australia, Australia
GSK Investigational SiteMelbourne, Australia
GSK Investigational SiteOttawa, Ontario, Canada
GSK Investigational SitePeterborough, Ontario, Canada
GSK Investigational SiteToronto, Ontario, Canada
GSK Investigational SiteGreenfield Park, Quebec, Canada
GSK Investigational SiteSherbrooke, Quebec, Canada
GSK Investigational SiteHelsinki, Finland
GSK Investigational SiteKuopio, Finland
GSK Investigational SiteOulu, Finland
GSK Investigational SiteTurku, Finland
GSK Investigational SiteBron, France
GSK Investigational SiteLille, France
GSK Investigational SiteNice, France
GSK Investigational SiteParis, France
GSK Investigational SiteParis, France
GSK Investigational SiteSaint-Herblain, France
GSK Investigational SiteStrasbourg, France
GSK Investigational SiteToulouse, France
GSK Investigational SiteVilleurbanne, France
GSK Investigational SiteCologne, Germany
GSK Investigational SiteErbach im Odenwald, Germany
GSK Investigational SiteMünchen, Germany
GSK Investigational SiteMünster, Germany
GSK Investigational SiteBrescia, Italy
GSK Investigational SiteCefalU PA, Italy
GSK Investigational SiteGenova, Italy
GSK Investigational SiteMilan, Italy
GSK Investigational SiteMilan, Italy
GSK Investigational SiteModena, Italy
GSK Investigational SiteMonza, Italy
GSK Investigational SitePavia, Italy
GSK Investigational SitePerugia, Italy
GSK Investigational Site's-Hertogenbosch, Netherlands
GSK Investigational SiteAmsterdam, Netherlands
GSK Investigational SiteZwolle, Netherlands
GSK Investigational SiteBergen, Norway
GSK Investigational SiteOslo, Norway
GSK Investigational SiteStavanger, Norway
GSK Investigational SiteJunggu, South Korea
GSK Investigational SiteSeoul, South Korea
GSK Investigational SiteSeoul, South Korea
GSK Investigational SiteBarcelona, Spain
GSK Investigational SiteGetxo - Vizcaya, Spain
GSK Investigational SiteMadrid, Spain
GSK Investigational SiteMadrid, Spain
GSK Investigational SiteMadrid, Spain
GSK Investigational SiteMadrid, Spain
GSK Investigational SitePamplona, Spain
GSK Investigational SiteSalamanca, Spain
GSK Investigational SiteTerrassa - Barcelona, Spain
GSK Investigational SiteValencia, Spain
GSK Investigational SiteGothenburg, Sweden
GSK Investigational SiteMalmö, Sweden
GSK Investigational SiteStockholm, Sweden
GSK Investigational SiteKaohsiung City, Taiwan
GSK Investigational SiteTainan, Taiwan
GSK Investigational SiteTau-Yuan, Taiwan
GSK Investigational SiteAnkara, Turkey (Türkiye)
GSK Investigational SiteCapaIstanbul, Turkey (Türkiye)
GSK Investigational SiteBirmingham, United Kingdom
GSK Investigational SiteBristol, United Kingdom
GSK Investigational SiteGlasgow, United Kingdom
GSK Investigational SiteLondon, United Kingdom
GSK Investigational SiteLondon, United Kingdom
GSK Investigational SiteLondon, United Kingdom